GIFLF Projected Dividend Yield
Ord Cl A/Grifols SA, Barcelona ( OTCBB : GIFLF )Grifols is a global pharmaceutical company developing, manufacturing and distributing a range of biological medicines based on plasma derived proteins. Co. organizes its business into several divisions, including: Bioscience, which includes activities relating to the manufacture of plasma derivatives for therapeutic use, and the sale and distribution of end products; Diagnostic, which focuses on researching, developing, manufacturing and marketing in vitro diagnostics products; Hospital, which provides technology and services for hospitals, clinics and other centers for the manufacture of medicines; and Bio Supplies, which primarily consists of biological products for non-therapeutic use. 17 YEAR PERFORMANCE RESULTS |
GIFLF Dividend History Detail GIFLF Dividend News GIFLF Competitors News |
Year |
Declaration Date |
Ex-Dividend Date |
Record Date |
Payable Date |
Dividend Amount (EUR) |
2020 |
N/A |
N/A |
Oct 27, 2020 |
Oct 28, 2020 |
0.1616 |
2020 Total: |
0.1616 |